Cytosorbents (CTSO) Non-Current Deferred Tax Liability (2018 - 2021)
Cytosorbents (CTSO) posted Non-Current Deferred Tax Liability of $183941.0 for Q4 2021, down 57.37% on a QoQ basis from $431490.0 in Q4 2020, and down 57.37% year-over-year from $431490.0 in Q4 2020.
Cytosorbents (CTSO) Non-Current Deferred Tax Liability (2018 - 2021) Analysis & Trends
Cytosorbents' Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $183941.0 for Q4 2021.
- Quarterly Non-Current Deferred Tax Liability fell 57.37% year-over-year to $183941.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $183941.0 (down 57.37% YoY) and the FY2021 annual result came in at $183941.0, down 57.37% from the prior year.
- Non-Current Deferred Tax Liability was $183941.0 for Q4 2021 at Cytosorbents, down from $431490.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $431490.0 in Q4 2020 and bottomed at $21856.0 in Q4 2018.
- A 4-year average of $257796.0 and a median of $288919.0 in 2019 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2019 — Non-Current Deferred Tax Liability soared 1702.24% — and 2021, when it slumped 57.37%.
- Cytosorbents' Non-Current Deferred Tax Liability stood at $21856.0 in 2018, then surged by 1702.24% to $393897.0 in 2019, then climbed by 9.54% to $431490.0 in 2020, then slumped by 57.37% to $183941.0 in 2021.
- Business Quant data shows CTSO's Non-Current Deferred Tax Liability at $183941.0 in Q4 2021, $431490.0 in Q4 2020, and $393897.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 183,941.00 |
| Dec 31, 2021 | 183,941.00 |
| Dec 31, 2020 | 431,490.00 |
| Dec 31, 2020 | 431,490.00 |
| Dec 31, 2019 | 393,897.00 |
| Dec 31, 2019 | 393,897.00 |
| Dec 31, 2018 | 21,856.00 |
| Dec 31, 2018 | 21,856.00 |